Rare genetic disease company Homology raises $125M follow-on

Homology raised $125 million in a follow-on priced late Tuesday to advance its pipeline of gene therapies.

Homology Medicines Inc. (NASDAQ:FIXX) sold 5.5 million shares at $22.50. The price represents a 24% discount to the company's closing price of $29.56 on Monday, when it proposed the offering after market hours. Homology shares fell $5.99 (20%) to $23.57 on Tuesday, and then dipped $1.46 to $22.11 on Wednesday...